| Net Cash Provided by (Used in) Operating Activities |
$431,649 |
USD |
-33% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
600,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
470,237,826 |
shares |
0.62% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$416,892 |
USD |
-76% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,855,356 |
USD |
|
Q2 2025 |
Q3 2025 |
| Depreciation |
$39,686 |
USD |
-5.5% |
Q2 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$248,606 |
USD |
1.2% |
Q2 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,855,356 |
USD |
|
Q2 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
$37,073,274 |
USD |
3.7% |
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
Q3 2025 |
| Interest Expense |
$215,577 |
USD |
-91% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |